Promoting best practice in pharmaceutical cold chain management across the Middle East and North Afr

by Events on 2010-10-05

It is estimated that the global biopharma cold chain market  will grow to $6.6 billion by 2011. This significant growth can be attributed to the industry’s push into emerging markets like the MENA.

The vaccine market, with the outbreak of H1N1 flu has also seen dramatic growth with an estimated 5% growth per year for the next 5 years. Adding to the volume is the regions growth in conducting clinical trials, as many biopharmaceuticals are coming off patent they look to the tax free haven of the MENA region to test and manufacture biosimilars.

The MENA region has identified and reacted to this activity with the development of world class logistics hubs and infrastructure that can facilitate air, ground and ocean carrier modes to the rest of the globe. Including Saudi Arabia’s $26.6 billion King Abdullah Economic City and the more established Jebel Ali Free Zone in the UAE.

As the Middle East pharma market continues to grow, there is an obvious focus on the conservation of temperature and humidity sensitive substances through the supply chain particularly through the summer months. This coupled with the challenges of un-unified cross boarder regulations across the MENA, there is a huge risk to patients and biopharma’s bottom line.

Cold Chain MENA will address how to monitor, control and manage temperatures and other associated risks to biopharma products from manufacturing across the whole supply chain to the end user. Also identifying best practice methodology in the region with global case studies. The interactive forum will also consider regulatory challenges throughout the region and suggest solutions to these challenges.

IQPC’s Cold Chain MENA summit will combine Supply Chain, Logistics and Quality leaders from Multi-national biopharma companies from the region and around the world as well as government and regulatory figures to discuss issues and proposed solutions that may occur across the supply chain.

Key topics of discussion include:

* Recognising best practice methods of controlling and monitoring temperature across the cold chain
* Identifying the importance of compliance with global regulatory standards to ensure drug integrity across the cold chain and translating it to the MENA region
* Assessing the challenges in outsourcing your logistics and supply chain and how to best manage this relationship to ensure quality service to customers
* Addressing cost-effective innovative tools and technologies across the logistics and cold chain that improve the efficiency, also considering biosimilars

Who will you meet at Cold Chain MENA summit?

Join leaders from multi-national pharmaceutical companies, government and regulatory boards with key job titles including:

Head, VP, Director, Manager, Scientists:

    * Supply Chain
    * Logistics
    * Quality Assurance/ Control
    * Warehouse/ Storage
    * Export/ Import
    * Packaging
    * Operations
    * Regulatory Affairs

For full details on the event including registration please visit http://www.coldchainmena.com/Event.aspx?id=331778
For a list of speakers visit http://www.coldchainmena.com/Event.aspx?id=347236